Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury.
Garcia B, Ter Schiphorst B, Santos K, Su F, Dewachter L, Vasques-Nóvoa F, Rocha-Oliveira E, Roncon-Albuquerque R Jr, Uba T, Hartmann O, Picod A, Azibani F, Callebert J, Goldman S, Annoni F, Favory R, Vincent JL, Creteur J, Taccone FS, Mebazaa A, Herpain A.
Garcia B, et al. Among authors: herpain a.
Intensive Care Med Exp. 2024 Jun 7;12(1):53. doi: 10.1186/s40635-024-00638-3.
Intensive Care Med Exp. 2024.
PMID: 38849640
Free PMC article.